FREE TO READ

Everything here is free to read, and nothing here is a claim about your case. Built from California’s published records and modified by us — not official government data. How these numbers were made.

Condition class · category · California

Mental health denials at external review

When a California health plan denied care for mental health and the enrollee took it to Independent Medical Review, this is what independent physician reviewers decided.

75.4%

Overturned
1,355 of 1,797
Era
2021-2025
Jurisdiction
California DMHC IMR
Published class
Mental Disorder
Median days to decision
31
All years
56.7% of 6,157
1,355 overturned442 upheld

What stands out here

computed from this class
  • among the highest

    At 75.4%, this is the 2nd highest overturn rate of the 24 conditiones with enough decisions to publish one. Reviewers sustained the plan in the remaining 24.6% of disputes.

  • the question matters

    The outcome turns on which question was put to the reviewer: 76.6% on medical necessity (n=1,745) against 36.7% on experimental/investigational (n=49) — a gap of 40 points inside the same condition.

  • rising

    It has risen over the published record: 42.4% in 2002 against 82.9% in 2025. What drove that is not in this data — the file holds outcomes, not who chose to appeal or how plans changed their own review.

  • most-cited standard

    Reviewers named LOCUS family more than any other standard here — 778 decisions, which came out at 81.7%. Citing a standard and the outcome share a cause; this is not the effect of naming it.

The trend, with its era

computed
0%25%50%75%100%SB 1410 field mandate82.9%200220052010201520202025Share of decisions overturning the health plan · years below n=30 omitted

Hover the chart for a year’s counts. Series stops at 2025 — report year 2026 uses a different category vocabulary.

What reviewers relied on

3 validated codes

California requires each published decision to carry “a detailed case summary that includes the specific standards, criteria, and medical and scientific evidence, if any, that led to the case decision” (Health & Safety Code § 1374.33(h)(1)(K)). These are the elements our extraction found in this class, split by how the decision came out.

What the reviewer relied onIn overturnsIn upholds
the FDA label or approval status3%n=1,3557%n=442
a standardised level-of-care instrument83%n=1,35560%n=442
a California statutory definition5%n=1,3558%n=442

Read as description, not instruction. These are patterns in what reviewers wrote, not steps to follow, and no combination of them predicts an outcome. Only codes that cleared the validation gate appear — thirteen did not.

Authorities named in this class

computed
  • LOCUS family81.7%778
  • American Society of Addiction Medicine79.1%580
  • American Academy of Child and Adolescent Psychiatry77.0%283
  • FDA58.9%73
  • WPATH82.0%50
  • American Psychiatric Association19
  • American Academy of Pediatrics2
  • American College of Obstetricians and Gynecologists2

A rate here is the outcome of decisions that named the authority, not the effect of naming it. Reviewers cite the standard they applied; the citation and the outcome share a cause.

By treatment

computed
  • Overturned — the reviewer did not sustain the denial
  • Upheld — the reviewer sustained the denial
  • Mental Health79.8%1,502
  • Pharmacy49.2%132
  • Reconstructive & plastic procedures74.2%62
  • Diagnostic imaging & screening13.3%30
  • Electro, thermal & radiofrequency20
  • Autism-related treatment9
  • Outpatient rehabilitation9
  • Durable medical equipment7

Browse all treatment classes · Pick your own pair

The specific treatments inside this class

below n=30, no rate is claimed
  • RTC79.1%1,122
  • Partial Hospital86.1%101
  • Intensive Outpt Prog90.3%93
  • Other55.6%54
  • TMS80.0%50
  • ADD/ADHD Rx63.6%44
  • Individ Counsel86.0%43
  • Anti-Depressants50.0%40

By review type

computed
  • Medical Necessity76.6%1,745
  • Experimental/Investigational36.7%49
  • Urgent Care3

Medical-necessity review asks whether the care is needed. Experimental/investigational review asks whether it is likely to be more beneficial than standard therapy — a harder statutory test, and the rates show it.

Every figure on this page is conditional on a denial having reached external review. Fewer than 1% of denials are appealed internally at all, so this describes denials that were fought to the end — not denials in general — and it describes California only. Who this does not cover.

Free help, first: the California DMHC Help Center files your Independent Medical Review at no cost — 1-888-466-2219, dmhc.ca.gov.